Comparison of astrocytic and myocytic metabolic dysregulation in apolipoprotein E deficient and human apolipoprotein E transgenic mice

Neuroscience

Volumn 98, Issue 2, 2000, Pages 353-359

  Robertson, T A ^a   Dutton, N S ^a   Martins, R N ^b   Taddei, K ^b   Papadimitriou, J M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

Author keywords

Apolipoprotein E; Astrocytic inclusions; Human apoE alleles; Mice; Sarcoplasmic inclusions; Skeletal muscle

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; TIBIALIS ANTERIOR MUSCLE; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; ASTROCYTES; HIPPOCAMPUS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE, SKELETAL;

EID: 0034076534     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00126-3     Document Type: Article

References (45)

1. Akaabourne M., Villanova M., Festoff B.W., Verdiere-Sahuque M., Hantai D. Apolipoprotein E expression at neuromuscular junctions in mouse rat and human skeletal muscle. Fedn Eur. Biochem. Socs Lett. 351:1994;246-248.
2. Akiyama H., Kameyama M., Akiguchi I., Sugiyama H., Kawamata T., Fukuyama H., Kimura H., Matsushita M., Takeda T. Periodic acid Schiff (PAS)-positive granular structures increase in the brain of senescence accelerated mouse (SAM). Acta neuropath. 72:1986;124-129.
3. Askanas V., Engel W.K., Renate B., Alverez M.S. Enhanced detection of Congo-red-positive amyloid deposits in muscle fibres of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology. 43:1993;1265-1267.
4. Askanas V., Mirabella M., Engel W.K., Alvarez R.B., Weisgraber K.H. Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet. 343:1994;364-365.
5. Boisvert W.A., Spangenberg J., Curtiss L.K. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. clin. Invest. 96:1995;1118-1124.
6. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., Fruchart J.C., Delacourte A., Rosser M., Amouyel P. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Human molec. Genet. 3:1994;569-574.
7. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:(5123):1993;921-923.
8. Dai X.Y., Nanko S., Hattori M., Fukuda R., Nagata K., Isse K., Ueki A., Kazamatsuri H. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci. Lett. 175:1994;74-76.
9. De Robertis E., Gerschenfeld H.M. Sub-microscopic morphology and function of glial cells. Int. Rev. Neurobiol. 3:1961;1-65.
10. Dubowitz V. Muscle Biopsy. A Practical Approach. 2nd :1985;Balliere Tindal, London.
11. Engel W.K., Bishop D.W., Cunningham G.G. Tubular aggregates in type II muscle fibres: ultrastructural and histochemical correlation. J. ultrastruct. Res. 31:1970;507-525.
12. Fazio S., Linton M.F. Murine bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism. Trends cardiovasc. Med. 6:1996;58-65.
13. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterisation of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120:1984;885-890.
14. Goldstein J.L., Brown M.S., Anderson R.G., Russell D.W., Schneider W.J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Ann. Rev. Cell Biol. 1:1985;1-39.
15. Grounds M.D. Skeletal muscle precursor cells do not arise from bone marrow cells. Cell Tiss. Res. 234:1983;713-722.
16. Herijgers N., Vaneck M., Groot P.H.E., Hoogerbrugge P.M., Vanberkel T.J.C. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor knockout. Arterioscl. Thromb. vasc. Biol. 17:1997;1995-2003.
17. Holtzman D.M., Bales K.R., Wu S., Bhat P., Parsadanian M., Fagan A.M., Chang L.K., Sun Y., Paul S.M. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. clin. Invest. 103:1999;R15-R21.
18. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci. Lett. 174:1994;222-224.
19. Jucker M., Walker L.C., Kuo H., Tian M., Ingram D.K. Age related fibrillar deposits in brains of C57BL/6 mice. Molec. Neurobiol. 9:1994b;125-133.
20. Jucker M., Walker L.C., Martin L.J., Kitt C.A., Kleinman H.K., Ingram D.K., Price D.L. Age-associated inclusions in normal and transgenic mouse brain. Science. 255:1992;1443-1444.
21. Jucker M., Walker L.C., Schwarb P., Hengemihle J., Kuo H., Snow A.D., Bamer F., Ingram D.K. Age-related deposition of glia-associated fibrillar material in brains of C57BL/J mice. Neuroscience. 60:1994a;875-889.
22. Kashyap V.S., Santamarinafojo S., Brown D.R., Parrott C.L., Applebaumbowden D., Meyn S., Talley G., Paigen B., Maeda N., Brewer H.B. Apolipoprotein e deficiency in mice-gene replacement and prevention of atherosclerosis using adenovirus vectors. J. clin. Invest. 96:1995;1612-1620.
23. Lamar C.H., Hinsman E.J., Henrikson C.K. Alterations in the hippocampus of aged mice. Acta neuropathol. 36:1976;387-391.
24. Linton M.F., Atkinson J.B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1995;1034-1037.
25. Mandybur T.I., Ormsby I., Zemlan F.P. Cerebral aging: a quantitative study of gliosis in old nude mice. Acta neuropathol. 77:1989;507-513.
26. Martins R.N., Clarnette R., Fisher C., Broe G.A., Brooks W.S., Montgomery P., Gandy S. ApoE genotypes in Australia:roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport. 6:1995;1513-1516.
27. Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
28. Mirabella M., Askanas V., Engel W.K. Immunocytochemical localisation of apolipoprotein E (ApoE) in inclusion body myositis (IBM). Neurology. 44:(2):1994;A347.
29. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscl. Thromb. 14:1994;133-140.
30. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S., Miyatake T., Mizusawa H., Kanazawal I. ApoE-epsilon 4 and early-onset Alzheimer's [letter]. Nature Genetics. 7:1994;10-11.
31. Piedrahita J.A., Zhang S.H., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 89:1992;4471-4475.
32. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
33. Robertson T.A., Dutton N.S., Martins R.D., Roses A.D., Kakulas B.A., Papadimitriou J.M. Age related congophilic inclusions in the brains of apoE deficient mice. Neuroscience. 82:1998;171-180.
34. Robertson T.A., Dutton N.S., Martins R.N., Roses A.D., Kakulas B.A., Papadimitriou J.M. β-amyloid protein containing inclusions in skeletal muscle of apoE deficient mice. Am. J. Path. 150:1997;417-427.
35. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
36. Stevenson S.C., Marshall-Neff J., Teng B., Lee C.B., Roy S., McClelland A. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer. Arterioscl. Thromb. vasc. Biol. 15:1995;479-484.
37. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;1977-1981.
38. Taddei K., Clarnette C., Gandy S.E., Martins R.N. Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci. Lett. 223:1997;29-32.
39. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:1993;166-168.
40. van Duijn C.M., de Knijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genetics. 7:1994;74-78.
41. Vaneck M., Herijgers N., Yates J., Pearce N.J., Hoogerbrugge P.M., Groot P.H.E., Vanberkel T.J.C. Bone marrow transplantation in apolipoprotein E deficient mice - Effect of apoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis. Arterioscl. Thromb. vasc. Biol. 17:1997;3117-3126.
42. Xu P.T., Schmechel D., Rothrock-Christiian T., Burkhart D.S., Qui H.-L., Popko B., Sullivan P., Maeda N., Saunders A.M., Roses A.D., Gilbert R.J. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in the central nervous system not observed in wild-type mice. Neurobiol. Dis. 3:1996;229-245.
43. Yang D.S., Small D.H., Seydel J.D., Hallmayer J., Gandy S.E., Martins R.N. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience. 90:1999;1217-1226.
44. Yang D.S., Smith J.D., Zhou Z., Gandy S.E., Martins R.N. Characterization of the binding of amyloid-b-peptide to cell culture-derived native apolipoprotein ε2, ε3 and ε4 isoforms and to isoforms from human plasma. J. Neurochem. 68:1997;721-725.
45. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.